Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S S Gangadin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Annual Review of Clinical Psychology|July 12, 2024
Immune Dysfunction in Schizophrenia Spectrum DisordersS S Gangadin, A D Enthoven, N J M van Beveren, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 9, 2026
External validation and recalibration of the Psychosis Metabolic Risk Calculator (PsyMetRiC) in young adults with chronic psychotic disorders in The NetherlandsD M C Quadackers, B I Perry, S S Gangadin, et al.
Schizophrenia Research|February 17, 2022
The neurobiological characterization of distinct cognitive subtypes in early-phase schizophrenia-spectrum disordersP P Oomen, S S Gangadin, M J H Begemann, et al.
Schizophrenia Research|September 7, 2023
Complement component 4A protein levels are negatively related to frontal volumes in patients with schizophrenia spectrum disordersS S Gangadin, M Germann, L D de Witte, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Annual Review of Clinical Psychology|July 12, 2024
Immune Dysfunction in Schizophrenia Spectrum DisordersS S Gangadin, A D Enthoven, N J M van Beveren, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 9, 2026
External validation and recalibration of the Psychosis Metabolic Risk Calculator (PsyMetRiC) in young adults with chronic psychotic disorders in The NetherlandsD M C Quadackers, B I Perry, S S Gangadin, et al.
Schizophrenia Research|February 17, 2022
The neurobiological characterization of distinct cognitive subtypes in early-phase schizophrenia-spectrum disordersP P Oomen, S S Gangadin, M J H Begemann, et al.
Schizophrenia Research|September 7, 2023
Complement component 4A protein levels are negatively related to frontal volumes in patients with schizophrenia spectrum disordersS S Gangadin, M Germann, L D de Witte, et al.
Pageof 1